Previous Article | Next Article 
Journal of Virology, February 2003, p. 2182-2194, Vol. 77, No. 3
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.3.2182-2194.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Cytomegalovirus-Mediated Upregulation of Chemokine Expression Correlates with the Acceleration of Chronic Rejection in Rat Heart Transplants
Daniel N. Streblow,1 Craig Kreklywich,1,2 Qiang Yin,2,3 V. T. De La Melena,2 Christopher L. Corless,3,4 Patricia A. Smith,1 Christina Brakebill,2 Judith W. Cook,2 Cornelis Vink,5 Cathrien A. Bruggeman,5 Jay A. Nelson,1,6 and Susan L. Orloff1,2,3*
Departments of Molecular Microbiology,1
Surgery,2
and Pathology,4
and The Gene Therapy Institute,6
Oregon Health Sciences University, and Portland Veterans Affairs Medical Center, Portland, Oregon 97201,3
and Department of Microbiology, University of Maastricht, Maastricht, The Netherlands5
Received 19 July 2002/
Accepted 28 October 2002
Cytomegalovirus (CMV) infections have been shown to dramatically affect solid organ transplant graft survival in both human and animal models. Recently, it was demonstrated that rat CMV (RCMV) infection accelerates the development of transplant vascular sclerosis (TVS) in both rat heart and small bowel graft transplants. However, the mechanisms involved in this process are still unclear. In the present study, we determined the kinetics of RCMV-accelerated TVS in a rat heart transplant model. Acute RCMV infection enhances the development of TVS in rat heart allografts, and this process is initiated between 21 and 24 days posttransplantation. The virus is consistently detected in the heart grafts from day 7 until day 35 posttransplantation but is rarely found at the time of graft rejection (day 45 posttransplantation). Grafts from RCMV-infected recipients had upregulation of chemokine expression compared to uninfected controls, and the timing of this increased expression paralleled that of RCMV-accelerated neointimal formation. In addition, graft vessels from RCMV-infected grafts demonstrate the increased infiltration of T cells and macrophages during periods of highest chemokine expression. These results suggest that CMV-induced acceleration of TVS involves the increased graft vascular infiltration of inflammatory cells through enhanced chemokine expression.
* Corresponding author. Mailing address: Department of Surgery, mc L590, 3181 SW Sam Jackson Park Rd., Portland, OR 97201. Phone: (503) 494-7810. Fax: (503) 494-5292. E-mail:
orloffs{at}ohsu.edu.
Journal of Virology, February 2003, p. 2182-2194, Vol. 77, No. 3
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.3.2182-2194.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Dumortier, J., Streblow, D. N., Moses, A. V., Jacobs, J. M., Kreklywich, C. N., Camp, D., Smith, R. D., Orloff, S. L., Nelson, J. A.
(2008). Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing. J. Virol.
82: 6524-6535
[Abstract]
[Full Text]
-
Stern, J. L., Slobedman, B.
(2008). Human Cytomegalovirus Latent Infection of Myeloid Cells Directs Monocyte Migration by Up-Regulating Monocyte Chemotactic Protein-1. J. Immunol.
180: 6577-6585
[Abstract]
[Full Text]
-
Verzijl, D., Storelli, S., Scholten, D. J., Bosch, L., Reinhart, T. A., Streblow, D. N., Tensen, C. P., Fitzsimons, C. P., Zaman, G. J. R., Pease, J. E., de Esch, I. J. P., Smit, M. J., Leurs, R.
(2008). Noncompetitive Antagonism and Inverse Agonism as Mechanism of Action of Nonpeptidergic Antagonists at Primate and Rodent CXCR3 Chemokine Receptors. J. Pharmacol. Exp. Ther.
325: 544-555
[Abstract]
[Full Text]
-
Bolovan-Fritts, C. A., Spector, S. A.
(2008). Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood
111: 175-182
[Abstract]
[Full Text]
-
Bolovan-Fritts, C. A., Trout, R. N., Spector, S. A.
(2007). High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood
110: 1857-1863
[Abstract]
[Full Text]
-
Gredmark, S., Straat, K., Homman-Loudiyi, M., Kannisto, K., Soderberg-Naucler, C.
(2007). Human Cytomegalovirus Downregulates Expression of Receptors for Platelet-Derived Growth Factor by Smooth Muscle Cells. J. Virol.
81: 5112-5120
[Abstract]
[Full Text]
-
Streblow, D. N., van Cleef, K. W. R., Kreklywich, C. N., Meyer, C., Smith, P., Defilippis, V., Grey, F., Fruh, K., Searles, R., Bruggeman, C., Vink, C., Nelson, J. A., Orloff, S. L.
(2007). Rat Cytomegalovirus Gene Expression in Cardiac Allograft Recipients Is Tissue Specific and Does Not Parallel the Profiles Detected In Vitro. J. Virol.
81: 3816-3826
[Abstract]
[Full Text]
-
Melnychuk, R. M., Smith, P., Kreklywich, C. N., Ruchti, F., Vomaske, J., Hall, L., Loh, L., Nelson, J. A., Orloff, S. L., Streblow, D. N.
(2005). Mouse Cytomegalovirus M33 Is Necessary and Sufficient in Virus-Induced Vascular Smooth Muscle Cell Migration. J. Virol.
79: 10788-10795
[Abstract]
[Full Text]
-
Lindenfeld, J., Page, R. L. II, Zolty, R., Shakar, S. F., Levi, M., Lowes, B., Wolfel, E. E., Miller, G. G.
(2005). Drug Therapy in the Heart Transplant Recipient: Part III: Common Medical Problems. Circulation
111: 113-117
[Full Text]
-
Bolovan-Fritts, C. A., Trout, R. N., Spector, S. A.
(2004). Human Cytomegalovirus-Specific CD4+-T-Cell Cytokine Response Induces Fractalkine in Endothelial Cells. J. Virol.
78: 13173-13181
[Abstract]
[Full Text]
-
van Leeuwen, E. M. M., Remmerswaal, E. B. M., Vossen, M. T. M., Rowshani, A. T., Wertheim-van Dillen, P. M. E., van Lier, R. A. W., ten Berge, I. J. M.
(2004). Emergence of a CD4+CD28- Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection. J. Immunol.
173: 1834-1841
[Abstract]
[Full Text]
-
Smith, L. M., Tonkin, J. N., Lawson, M. A., Shellam, G. R.
(2004). Isolates of cytomegalovirus (CMV) from the black rat Rattus rattus form a distinct group of rat CMV. J. Gen. Virol.
85: 1313-1317
[Abstract]
[Full Text]
-
Umehara, H., Bloom, E. T., Okazaki, T., Nagano, Y., Yoshie, O., Imai, T.
(2004). Fractalkine in Vascular Biology: From Basic Research to Clinical Disease. Arterioscler. Thromb. Vasc. Bio.
24: 34-40
[Abstract]
[Full Text]